Health care industry

FILE - This undated photo provided by Maricopa County Sheriff's Office shows Nathan Sutherland, who is charged with sexually assaulting an incapacitated woman who later gave birth at a long-term care facility in Phoenix. Sutherland has appealed a court order requiring a test to determine if he has HIV and other sexually transmitted diseases. (Maricopa County Sheriff's Office via AP, File)
May 20, 2019 - 5:41 pm
PHOENIX (AP) — A former nurse charged with sexually assaulting an incapacitated woman who later gave birth at a Phoenix long-term care facility has appealed a court order requiring a test to determine if he has HIV or other sexually transmitted diseases. A lawyer for Nathan Sutherland says in an...
Read More
May 20, 2019 - 2:12 pm
WASHINGTON (AP) — The Supreme Court said Monday that a judge must decide whether a dispute between drugmaker Merck and patients who alleged they were injured by its bone-strengthening drug Fosamax can go forward. All nine justices agreed that the case should go back to a lower court for further...
Read More
Rep. Anna Eshoo, D-Calif., right, chair of the House Health Subcommittee, says President Donald Trump and Attorney General William Barr want to take a sledgehammer to health care, as she joins, from left, Rep. Lisa Blunt Rochester, D-Del., House Speaker Nancy Pelosi, D-Calif., and Senate Minority Leader Chuck Schumer, D-N.Y., at a Democratic event ahead of a House floor vote on the Health Care and Prescription Drug Package, at the Capitol in Washington, Wednesday, May 15, 2019. (AP Photo/J. Scott Applewhite)
May 16, 2019 - 7:07 pm
WASHINGTON (AP) — Democrats pushed legislation buttressing the 2010 health care law and curbing prescription drug prices through the House Thursday, advancing a bill that has no chance of surviving in the Senate or getting President Donald Trump's signature and seemed engineered with next year's...
Read More
FILE - This July 6, 2017 file photo shows prescription drugs in a glass flask at the state crime lab in Taylorsville, Utah. Attorneys general from more than 40 states are alleging the nation's largest generic drug manufacturers conspired to artificially inflate and manipulate prices for more than 100 different generic drugs, including treatments for diabetes, cancer, arthritis and other medical conditions. The lawsuit, filed in federal court Friday, May 10, 2019 also names 15 individual senior executives responsible for sales, marketing and pricing. (AP Photo/Rick Bowmer, File)
May 11, 2019 - 2:13 pm
BOSTON (AP) — Attorneys general from more than 40 states are alleging the nation's largest generic drug manufacturers conspired to artificially inflate and manipulate prices for more than 100 different generic drugs, including treatments for diabetes, cancer, arthritis and other medical conditions...
Read More
President Donald Trump speaks during a event on medical billing, in the Roosevelt Room of the White House, Thursday, May 9, 2019, in Washington. (AP Photo/Evan Vucci)
May 09, 2019 - 11:59 am
WASHINGTON (AP) — The Latest on President Donald Trump's effort to limit "surprise medical bills" (all times local): 1 p.m. President Donald Trump is ratcheting up pressure on the pharmaceutical industry to lower prices and announcing a new effort to end "surprise medical bills" for patients with...
Read More
FILE - In this March 13, 2019, file phtooHealth and Human Services Secretary Alex Azar testifies before a House Appropriations subcommittee on Capitol Hill in Washington. Azar says drugmakers will soon have to reveal prices of their prescription medicines in those ever-present TV ads. The Trump administration will issue final regulations on May 8 requiring drug companies to disclose list prices of medications costing more than $35 for a month’s supply. Azar tells The Associated Press if drugmakers are scared to put prices in ads that means they should lower those prices. (AP Photo/Susan Walsh, File)
May 08, 2019 - 9:01 am
WASHINGTON (AP) — Those ever-present TV ads for prescription drugs will soon carry prices, too, the nation's top health official said Wednesday, responding to a public outcry for government action to restrain medication costs. Health and Human Services Secretary Alex Azar said the Trump...
Read More
A report released on Thursday, May 2, 2019, by the Congressional Budget Office is photographed in Washington. Budget experts for Congress say the Trump administration’s plan to reduce out-of-pocket drug costs for Medicare beneficiaries will cost taxpayers another $177 billion from 2020-2029. (AP Photo/Jon Elswick)
May 02, 2019 - 6:49 pm
WASHINGTON (AP) — The Trump administration's plan to ease the financial hit of prescription drugs prices for Medicare beneficiaries will cost taxpayers another $177 billion over 10 years, congressional budget experts said on Thursday. The estimates from the nonpartisan Congressional Budget Office...
Read More
Democratic presidential candidate Sen. Bernie Sanders, I-Vt., Bernie Sanders speaks during a rally at Discovery Green on Wednesday, April 24, 2019, in Houston. (Brett Coomer/Houston Chronicle via AP)
May 01, 2019 - 3:12 pm
WASHINGTON (AP) — Congressional budget experts said Wednesday that moving to a government-run health care system like "Medicare for All" could be complicated and potentially disruptive for Americans. The report from the nonpartisan Congressional Budget Office was a high-level look at the pros and...
Read More
FILE - In this March 18, 2019, file photo trader Joseph Lawler works on the floor of the New York Stock Exchange. The U.S. stock market opens at 9:30 a.m. EDT on Tuesday, April 30. (AP Photo/Richard Drew, File)
April 30, 2019 - 4:05 pm
Wall Street capped a day of mostly wobbly trading with meager gains Tuesday, enough to nudge the S&P 500 to an all-time high for the third straight day. The benchmark index spent much of the day hovering below its previous high, but edged up in the last few minutes of trading. Household goods...
Read More
In this Friday, April 26, 2019 photo, a box of RELPAX migraine pills manufactured by Pfizer are arranged for a photo in Doral, Fla. Pfizer Inc. reports financial results Tuesday, April 30. (AP Photo/Wilfredo Lee)
April 30, 2019 - 2:27 pm
Higher prescription drugs sales and restrained spending together gave drugmaker Pfizer a 9% jump in first quarter profit as it easily topped analysts' profit expectations. Investors drove up Pfizer shares $1.20, or 3%, to $40.79 in early afternoon trading. Sales of breast cancer drug Ibrance and...
Read More

Pages